Following the round of pre-recorded submissions in April, the stage is set for the 2026 BU Three Minute Thesis (3MT®) Final.
PGRs face the ultimate academic challenge: condensing complex thesis data into a single, high-impact, three-minute presentation for a general audience.

Why We Need You in the Audience
Our PGRs have worked hard to master the ultimate “elevator pitch.” Having a strong, supportive audience of BU colleagues and peers makes a massive difference to their presentation energy.
By attending, you are not only supporting your faculty’s researchers but also actively contributing to the judging process. Alongside the main panel prizes, attendees will have the opportunity to cast their vote for the coveted People’s Choice Award.
Finalists are competing for national recognition at the National Vitae 3MT competition, alongside top prizes including £150, £100, and £50 vouchers.
Event Details
Wednesday 17 June, 1-3pm
Create Lecture Theatre, Fusion Building, Talbot Campus
Find out more and register here
Spaces are limited. Please secure your seat and support our research community
For further details about the competition framework, please visit the Doctoral College Brightspace page or contact the team at pgrskillsdevelopment@bournemouth.ac.uk












Three Minute Thesis (3MT®) 2026: Register to Support our PGRs
Expressions of Interest invited for Research Ethics Roles starting in 2026/27
Expressions of Interest invited from senior academics to join the BU REF Appeals Panel
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
First publication for two CMWH PhD students
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease